Hidden in Heart Failure
Current diagnostic strategies fail to illuminate the presence of rare disease in the heart failure population. One-third of heart failure patients are categorised as suffering an idiopathic dilated cardiomyopathy, while others are labelled only as heart failure with preserved ejection fraction. Thos...
Guardado en:
Autores principales: | , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Radcliffe Medical Media
2019
|
Materias: | |
Acceso en línea: | https://doaj.org/article/b1ecb8a7737344ac8e50164730f3e52b |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:b1ecb8a7737344ac8e50164730f3e52b |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:b1ecb8a7737344ac8e50164730f3e52b2021-12-04T16:01:40ZHidden in Heart Failure10.15420/ecr.2019.19.21758-37641758-3756https://doaj.org/article/b1ecb8a7737344ac8e50164730f3e52b2019-07-01T00:00:00Zhttps://www.ecrjournal.com/articles/hidden-in-heart-failurehttps://doaj.org/toc/1758-3756https://doaj.org/toc/1758-3764Current diagnostic strategies fail to illuminate the presence of rare disease in the heart failure population. One-third of heart failure patients are categorised as suffering an idiopathic dilated cardiomyopathy, while others are labelled only as heart failure with preserved ejection fraction. Those affected frequently suffer from delays in diagnosis, which can have a significant impact on quality of life and prognosis. Traditional rhetoric argues that delineation of this patient population is superfluous to treatment, as elucidation of aetiology will not lead to a deviation from standard management protocols. This article emphasises the importance of identifying genetic, inflammatory and infiltrative causes of heart failure to enable patients to access tailored management strategies.Douglas Ewan CannieMohammed Majid AkhtarPerry ElliottRadcliffe Medical MediaarticleDiseases of the circulatory (Cardiovascular) systemRC666-701ENEuropean Cardiology Review , Vol 14, Iss 2, Pp 89-96 (2019) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Diseases of the circulatory (Cardiovascular) system RC666-701 |
spellingShingle |
Diseases of the circulatory (Cardiovascular) system RC666-701 Douglas Ewan Cannie Mohammed Majid Akhtar Perry Elliott Hidden in Heart Failure |
description |
Current diagnostic strategies fail to illuminate the presence of rare disease in the heart failure population. One-third of heart failure patients are categorised as suffering an idiopathic dilated cardiomyopathy, while others are labelled only as heart failure with preserved ejection fraction. Those affected frequently suffer from delays in diagnosis, which can have a significant impact on quality of life and prognosis. Traditional rhetoric argues that delineation of this patient population is superfluous to treatment, as elucidation of aetiology will not lead to a deviation from standard management protocols. This article emphasises the importance of identifying genetic, inflammatory and infiltrative causes of heart failure to enable patients to access tailored management strategies. |
format |
article |
author |
Douglas Ewan Cannie Mohammed Majid Akhtar Perry Elliott |
author_facet |
Douglas Ewan Cannie Mohammed Majid Akhtar Perry Elliott |
author_sort |
Douglas Ewan Cannie |
title |
Hidden in Heart Failure |
title_short |
Hidden in Heart Failure |
title_full |
Hidden in Heart Failure |
title_fullStr |
Hidden in Heart Failure |
title_full_unstemmed |
Hidden in Heart Failure |
title_sort |
hidden in heart failure |
publisher |
Radcliffe Medical Media |
publishDate |
2019 |
url |
https://doaj.org/article/b1ecb8a7737344ac8e50164730f3e52b |
work_keys_str_mv |
AT douglasewancannie hiddeninheartfailure AT mohammedmajidakhtar hiddeninheartfailure AT perryelliott hiddeninheartfailure |
_version_ |
1718372754953076736 |